Clinical Trials Browser

Phase 2 × Rectal Neoplasms × LY-2157299 × Clear all

NCT02688712 2026-04-13

ExIST Study of LY2157299 (Galunisertib) in Rectal Cancer

Phase 2 Active not recruiting

Gastrointestinal

Rectal Neoplasms